查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1702218

2025 年至 2033 年體外診斷市場規模、佔有率、趨勢及預測（按測試類型、產品、可用性、應用、最終用戶和地區）

In Vitro Diagnostics Market Size, Share, Trends and Forecast by Test Type, Product, Usability, Application, End User, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球體外診斷市場規模價值 1,167 億美元。展望未來， IMARC Group估計到 2033 年市場規模將達到 1,815 億美元，2025 年至 2033 年的複合年成長率為 5.0%。北美目前佔據市場主導地位，到 2024 年其市佔率將超過 42.7%。傳染病患病率的上升、技術的不斷進步、消費者偏好向個人化醫療的轉變以及老年人口的增加是推動體外診斷市場佔有率的主要因素。

體外診斷 (IVD) 是指在生物體外進行的醫學測試和程序，通常在實驗室環境中，使用血液、尿液、組織或其他體液等樣本。這些測試旨在檢測、診斷和監測各種醫療狀況和疾病。與在生物體內進行的體內診斷不同，體外診斷涉及在受控實驗室條件下檢查生物樣本。 IVD 測試是現代醫療保健不可或缺的一部分，為醫療保健專業人員提供關鍵訊息，以便他們就患者護理做出明智的決策。這些測試在疾病篩檢、早期診斷、治療選擇和監測治療進展中發揮著至關重要的作用。它們應用於各醫學專業，包括臨床化學、微生物學、血液學、免疫學、分子診斷學等。

由於慢性病和傳染病的發病率不斷上升，市場正在經歷顯著成長。隨著人口老化和生活方式的改變，糖尿病、心血管疾病和癌症等慢性疾病變得更加普遍。體外診斷為醫療保健專業人員提供了這些疾病的早期發現和有效管理的重要見解，從而改善了患者的治療效果並降低了醫療保健成本。此外，技術進步和自動化整合徹底改變了 IVD 市場。自動化系統（例如即時診斷設備和分子診斷）簡化了診斷過程，從而能夠更快、更準確地獲得結果。此外，人們對個人化醫療和精準診斷的日益關注也推動了對專門體外診斷測試的需求。這些測試有助於根據個別患者的特定基因和分子特徵制定治療計劃，最佳化治療結果並最大限度地減少不良反應。

體外診斷市場趨勢/促進因素：

各種技術進步與自動化

技術創新的快速步伐徹底改變了體外診斷（IVD）市場。分子診斷、次世代定序和微流體等先進技術使得檢測方法更加準確和靈敏。自動化簡化了診斷流程，減少了人為錯誤並提高了效率。諸如即時診斷測試設備之類的自動化系統可以更快地獲得結果，從而能夠及時做出患者護理決策。這些進步不僅提高了診斷的準確性，而且還有助於節省成本和改善患者的治療效果。此外，自動化將診斷測試的範圍擴展到偏遠或資源有限的地區，解決了醫療保健差距並改善了患者獲得基本診斷服務的機會。人工智慧和機器學習演算法的融合進一步增強了診斷系統的分析能力，使得測試解釋更加精確和個人化。隨著技術的不斷進步，體外診斷市場預計將持續成長，診斷測試和應用的範圍也將持續擴大。

慢性病盛行率不斷上升

糖尿病、心血管疾病和癌症等慢性疾病的盛行率不斷上升，成為 IVD 市場成長的主要驅動力。隨著人口老化和生活方式的改變，慢性病在全球範圍內變得更加普遍。體外診斷在這些疾病的早期發現、監測和管理中發揮著至關重要的作用。診斷測試可幫助醫療保健專業人員做出明智的治療決策，從而更好地管理疾病並改善患者的生活品質。此外，慢性病的流行促使人們轉向預防性醫療保健。早期發現和介入對於預防慢性病進展和減輕醫療系統負擔至關重要。體外診斷有助於早期篩檢和識別風險因素，從而及時採取預防措施。對預防性醫療保健的重視促使人們在常規健康檢查和健康計劃中採用 IVD 測試。

個人化醫療日益受到重視

人們對個人化醫療的日益關注對 IVD 市場產生了重大影響。個人化醫療旨在根據患者的基因組成、生活方式和其他因素為其量身定做醫療方案。體外診斷，例如基因檢測和伴隨診斷，可以提供有關患者獨特特徵的關鍵見解，從而實現有針對性的治療並避免不必要的治療或不良反應。精準診斷借助下一代定序 (NGS) 和伴隨診斷等先進技術，有助於識別特定的疾病亞型和分子標靶。隨著精準醫療日益受到重視，對專門診斷測試的需求持續上升。醫療保健提供者和製藥公司正在增加對研發的投資，以識別新的生物標記並創造創新的診斷解決方案來支持精準醫療計劃。

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球體外診斷市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依測試類型

  • 臨床化學
  • 分子診斷
  • 免疫診斷
  • 血液學
  • 其他

第7章：市場區隔：依產品

  • 試劑和試劑盒
  • 儀器

第8章：市場區隔：依可用性

  • 免洗體外診斷設備
  • 可重複使用的體外診斷設備

第9章：市場區隔：依應用

  • 傳染病
  • 糖尿病
  • 癌症/腫瘤學
  • 心臟病學
  • 自體免疫疾病
  • 腎臟病學
  • 其他

第10章：市場區隔：依最終用戶

  • 醫院實驗室
  • 臨床實驗室
  • 即時檢驗中心
  • 學術機構
  • 患者
  • 其他

第 11 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第 12 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 13 章：價值鏈分析

第 14 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 15 章：價格分析

第 16 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Agilent Technologies Inc.
    • Biomerieux SA
    • Bio-Rad Laboratories Inc.
    • F. Hoffmann-La Roche Ltd
    • Fujifilm Holdings Corporation
    • Illumina Inc.
    • Qiagen NV
    • Quest Diagnostics
    • Shimadzu Corporation
    • Siemens Healthcare GmbH
    • Sysmex Corporation
Product Code: SR112025A6467

The global in vitro diagnostics market size was valued at USD 116.7 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 181.5 Billion by 2033, exhibiting a CAGR of 5.0% from 2025-2033. North America currently dominates the market, holding a market share of over 42.7% in 2024. The rising prevalence of infectious diseases, the continuous technological advancements, shifting consumer preferences towards personalized medicine, and increasing geriatric population are among the primary factors driving the in vitro diagnostics market share.

In vitro diagnostics (IVD) refers to medical tests and procedures that are performed outside the living organism, typically in a laboratory setting, using samples such as blood, urine, tissue, or other body fluids. These tests are designed to detect, diagnose, and monitor various medical conditions and diseases. Unlike in vivo diagnostics, which are conducted within the living body, in vitro diagnostics involve the examination of biological specimens in controlled laboratory conditions. IVD tests are an integral part of modern healthcare, providing crucial information to healthcare professionals for making informed decisions about patient care. These tests play a vital role in disease screening, early diagnosis, treatment selection, and monitoring treatment progress. They are used across various medical specialties, including clinical chemistry, microbiology, hematology, immunology, molecular diagnostics, and more.

The market is experiencing significant growth, driven by the increasing prevalence of chronic diseases and infectious conditions. With the rise in aging populations and lifestyle changes, chronic diseases such as diabetes, cardiovascular disorders, and cancer have become more prevalent. In vitro diagnostics provide healthcare professionals with essential insights into the early detection and effective management of these conditions, leading to improved patient outcomes and reduced healthcare costs. Moreover, advancements in technology and the integration of automation have revolutionized the IVD market. Automated systems, such as point-of-care testing devices and molecular diagnostics, have streamlined the diagnostic process, enabling faster and more accurate results. Additionally, the growing focus on personalized medicine and precision diagnostics has boosted the demand for specialized in vitro diagnostic tests. These tests help tailor treatment plans to individual patients' specific genetic and molecular characteristics, optimizing therapeutic outcomes and minimizing adverse reactions.

In Vitro Diagnostics Market Trends/Drivers:

Various technological advancements and automation

The rapid pace of technological innovation has revolutionized the In vitro diagnostics (IVD) market. Advanced technologies, such as molecular diagnostics, next-generation sequencing, and microfluidics, have enabled more accurate and sensitive testing methods. Automation has streamlined diagnostic processes, reducing human errors and increasing efficiency. Automated systems like point-of-care testing devices have facilitated faster results, enabling timely decision-making in patient care. These advancements not only enhance diagnostic accuracy but also contribute to cost savings and improved patient outcomes. Moreover, automation has extended the reach of diagnostic testing to remote or resource-limited areas, addressing healthcare disparities and improving patient access to essential diagnostic services. The integration of artificial intelligence and machine learning algorithms has further enhanced the analytical capabilities of diagnostic systems, allowing for more precise and personalized test interpretations. As technology continues to advance, the In vitro diagnostics market is expected to witness continued growth, with an ever-expanding range of diagnostic tests and applications.

The increasing prevalence of chronic diseases

The rising prevalence of chronic diseases, such as diabetes, cardiovascular disorders, and cancer, has been a key driver in the growth of the IVD market. With aging populations and lifestyle changes, chronic conditions have become more prevalent globally. In vitro diagnostics play a crucial role in the early detection, monitoring, and management of these diseases. Diagnostic tests assist healthcare professionals in making informed treatment decisions, leading to better disease management and improved quality of life for patients. Moreover, the prevalence of chronic diseases has prompted a paradigm shift towards preventive healthcare. Early detection and intervention are essential in preventing the progression of chronic conditions and reducing the burden on healthcare systems. In vitro diagnostics facilitate early screening and identification of risk factors, enabling timely preventive measures. This emphasis on preventive healthcare has spurred the adoption of IVD tests in routine health check-ups and wellness programs.

The growing emphasis on personalized medicine

The growing focus on personalized medicine has significantly impacted the IVD market. Personalized medicine aims to tailor medical treatment to individual patients based on their genetic makeup, lifestyle, and other factors. In vitro diagnostics, such as genetic testing and companion diagnostics, provide critical insights into patients' unique characteristics, enabling targeted therapies and avoiding unnecessary treatments or adverse reactions. Precision diagnostics, enabled by advanced technologies like Next-Generation Sequencing (NGS) and companion diagnostics, facilitate the identification of specific disease subtypes and molecular targets. As precision medicine gains prominence, the demand for specialized diagnostic tests continues to rise. Healthcare providers and pharmaceutical companies are increasingly investing in research and development to identify new biomarkers and create innovative diagnostic solutions to support precision medicine initiatives.

In Vitro Diagnostics Industry Segmentation:

Breakup by Test Type:

  • Clinical Chemistry
  • Molecular Diagnostics
  • Immunodiagnostics
  • Hematology
  • Others

Molecular diagnostics represents the most popular test type

Molecular diagnostics offer high levels of accuracy and sensitivity in disease detection. They can identify even low concentrations of target molecules, enabling early diagnosis and precise monitoring of diseases. This level of sensitivity is particularly crucial in the detection of infectious diseases, genetic disorders, and certain types of cancer, where early intervention is vital for successful treatment. Moreover, molecular diagnostics play a key role in the advancement of personalized medicine. By analyzing an individual's genetic makeup or specific biomarkers, these tests can tailor treatment plans to each patient's unique characteristics. This approach optimizes therapeutic outcomes, minimizes adverse effects, and enhances overall patient care, contributing to the growing demand for personalized healthcare solutions.

Breakup by Product:

  • Reagents and Kits
  • Instruments

Reagents and kits represent the leading segment

Reagents and kits are fundamental components of diagnostic tests. They contain the necessary substances and chemicals required to perform specific assays and analyze patient samples. Diagnostic laboratories and healthcare facilities rely heavily on reagents and kits to conduct a wide range of tests, from routine screenings to complex molecular diagnostics. Moreover, Reagents and kits are designed to be user-friendly and standardized, ensuring consistent and reliable results across different laboratories and testing sites. They simplify the testing process, reducing the need for extensive manual preparation and minimizing the risk of errors. Standardization also facilitates inter-laboratory comparability, making it easier for healthcare providers to interpret and act upon test results.

Breakup by Usability:

  • Disposable IVD Devices
  • Reusable IVD Devices

Disposable IVD devices are designed for single-use and are discarded after a single patient interaction or testing procedure. They are pre-sterilized and come in a ready-to-use format, which eliminates the need for cleaning, disinfection, or reprocessing after each use. Healthcare providers find disposable IVD devices convenient and time-saving, as they eliminate the need for complex and time-consuming reprocessing procedures. This is especially advantageous in high-volume testing environments.

Reusable IVD devices, as the name suggests, can be used multiple times after appropriate cleaning, sterilization, and maintenance. They are made of durable materials that can withstand repeated use without compromising their performance. They also offer greater flexibility in terms of test customization and parameter adjustments, making them suitable for research and specialized testing needs.

Breakup by Application:

  • Infectious Disease
  • Diabetes
  • Cancer/Oncology
  • Cardiology
  • Autoimmune Disease
  • Nephrology
  • Others

Infectious diseases currently dominate the market

Infectious diseases pose significant global health challenges, and outbreaks or pandemics can have severe consequences on public health and economies. The COVID-19 pandemic, for example, has highlighted the critical role of diagnostic testing in controlling the spread of infectious diseases. Besides, infectious diseases have a high incidence and prevalence rate, affecting millions of people worldwide. Common infectious diseases such as influenza, tuberculosis, hepatitis, and sexually transmitted infections continue to impact communities across the globe. Moreover, in vitro diagnostics offer a rapid and reliable way to identify infectious agents, allowing healthcare providers to initiate appropriate therapies, implement infection control measures, and prevent further transmission.

Breakup by End User:

  • Hospitals Laboratories
  • Clinical Laboratories
  • Point-of-care Testing Centers
  • Academic Institutes
  • Patients
  • Others

Hospital laboratories are an essential part of healthcare facilities, providing diagnostic testing services to inpatients and outpatients. These laboratories are equipped with a wide range of IVD instruments and reagents to perform various tests, including clinical chemistry, hematology, microbiology, and immunology. Hospitals rely on timely and accurate diagnostic results from their in-house laboratories to aid in patient diagnosis, treatment, and disease management.

Clinical laboratories, also known as independent or reference laboratories, are separate entities that offer diagnostic testing services to healthcare providers, hospitals, clinics, and other healthcare settings. They often handle high-volume and specialized tests that may not be available in all hospital laboratories. Clinical laboratories serve as centralized testing facilities, supporting multiple healthcare facilities with their comprehensive testing capabilities.

Point-of-care testing (POCT) centers represent a rapidly growing segment in the IVD market. These centers provide diagnostic tests at or near the location where patient care is delivered. POCT devices offer rapid results, allowing for immediate treatment decisions and interventions. Point-of-care testing centers are especially valuable in emergency rooms, ambulances, nursing homes, and remote or resource-limited settings where quick diagnosis is critical.

Academic institutes, including research universities and medical schools, contribute to the IVD market through research, development, and education. They play a pivotal role in advancing diagnostic technologies, discovering new biomarkers, and evaluating the effectiveness of diagnostic tests. Academic institutes often collaborate with diagnostic companies to conduct clinical trials and validate the performance of novel diagnostic assays.

Patients are becoming increasingly involved in their healthcare decisions, including diagnostic testing. The IVD market caters to the direct-to-consumer testing trend, where patients can access certain diagnostic tests without a healthcare provider's prescription. These tests allow individuals to monitor their health status, identify risk factors, and take proactive steps towards better health management.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America accounts for the majority of market share

The report has also provided a comprehensive analysis of all the major regional markets, which includes North America (United States, Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others); Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others); Latin America (Brazil, Mexico, Others); and the Middle East and Africa. According to the report, North America was the largest market for in vitro diagnostics.

North America boasts a well-developed and advanced healthcare infrastructure, including modern hospitals, clinical laboratories, and research institutions. The region's robust healthcare system supports a high volume of diagnostic testing, driving the demand for IVD products and services. Besides, North America is at the forefront of technological innovations in the IVD industry. The region is home to many leading diagnostic companies and research institutions that invest heavily in research and development, leading to the creation of cutting-edge diagnostic technologies and products. Moreover, the region has stringent regulatory standards for diagnostic products, ensuring safety and efficacy. Companies operating in the region must comply with rigorous quality control measures, which helps build trust in the reliability of IVD products.

Competitive Landscape:

The competitive landscape of the In vitro diagnostics (IVD) market is characterized by a diverse and highly competitive environment, with numerous companies vying for market share. They are developing advanced technologies, novel biomarkers, and point-of-care testing devices to meet the evolving needs of the healthcare industry. They are engaging in mergers and acquisitions (M&As) to expand their product portfolios, gain access to new markets, and enhance their technological capabilities. They are also expanding their market presence by establishing distribution networks in new regions or countries. Moreover, companies are embracing digitalization and investing in digital diagnostic solutions. This includes the development of digital pathology, remote monitoring, and telehealth solutions to enhance diagnostic efficiency and accessibility.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Biomerieux SA
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd
  • Fujifilm Holdings Corporation
  • Illumina Inc.
  • Qiagen N.V
  • Quest Diagnostics
  • Shimadzu Corporation
  • Siemens Healthcare GmbH
  • Sysmex Corporation

Key Questions Answered in This Report

  • 1.What is the IVD market?
  • 2.What is the global outlook on the in vitro diagnostics industry?
  • 3.What is the market size of in vitro diagnostics?
  • 4.What are the key factors driving the in vitro diagnostics market?
  • 5.Which region accounts for the largest in vitro diagnostics market share?
  • 6.Which are the leading companies in the global in vitro diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global In Vitro Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Test Type

  • 6.1 Clinical Chemistry
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Molecular Diagnostics
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Immunodiagnostics
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Hematology
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Reagents and Kits
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Instruments
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Usability

  • 8.1 Disposable IVD Devices
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Reusable IVD Devices
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Infectious Disease
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Diabetes
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Cancer/Oncology
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Cardiology
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Autoimmune Disease
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast
  • 9.6 Nephrology
    • 9.6.1 Market Trends
    • 9.6.2 Market Forecast
  • 9.7 Others
    • 9.7.1 Market Trends
    • 9.7.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Hospitals Laboratories
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Clinical Laboratories
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Point-of-care Testing Centers
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Academic Institutes
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Patients
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast
  • 10.6 Others
    • 10.6.1 Market Trends
    • 10.6.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Abbott Laboratories
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Agilent Technologies Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
      • 16.3.2.4 SWOT Analysis
    • 16.3.3 Biomerieux SA
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
      • 16.3.3.4 SWOT Analysis
    • 16.3.4 Bio-Rad Laboratories Inc.
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
      • 16.3.4.4 SWOT Analysis
    • 16.3.5 F. Hoffmann-La Roche Ltd
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 SWOT Analysis
    • 16.3.6 Fujifilm Holdings Corporation
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
      • 16.3.6.4 SWOT Analysis
    • 16.3.7 Illumina Inc.
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 Qiagen NV
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
    • 16.3.9 Quest Diagnostics
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Shimadzu Corporation
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
      • 16.3.10.4 SWOT Analysis
    • 16.3.11 Siemens Healthcare GmbH
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
    • 16.3.12 Sysmex Corporation
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
      • 16.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: In Vitro Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: In Vitro Diagnostics Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: In Vitro Diagnostics Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: In Vitro Diagnostics Market: Breakup by Test Type (in %), 2024
  • Figure 5: Global: In Vitro Diagnostics Market: Breakup by Product (in %), 2024
  • Figure 6: Global: In Vitro Diagnostics Market: Breakup by Usability (in %), 2024
  • Figure 7: Global: In Vitro Diagnostics Market: Breakup by Application (in %), 2024
  • Figure 8: Global: In Vitro Diagnostics Market: Breakup by End User (in %), 2024
  • Figure 9: Global: In Vitro Diagnostics Market: Breakup by Region (in %), 2024
  • Figure 10: Global: In Vitro Diagnostics (Clinical Chemistry) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: In Vitro Diagnostics (Clinical Chemistry) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: In Vitro Diagnostics (Molecular Diagnostics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: In Vitro Diagnostics (Molecular Diagnostics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: In Vitro Diagnostics (Immunodiagnostics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: In Vitro Diagnostics (Immunodiagnostics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: In Vitro Diagnostics (Hematology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: In Vitro Diagnostics (Hematology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: In Vitro Diagnostics (Other Test Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: In Vitro Diagnostics (Other Test Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: In Vitro Diagnostics (Reagents and Kits) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: In Vitro Diagnostics (Reagents and Kits) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: In Vitro Diagnostics (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: In Vitro Diagnostics (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: In Vitro Diagnostics (Disposable IVD Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: In Vitro Diagnostics (Disposable IVD Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: In Vitro Diagnostics (Reusable IVD Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: In Vitro Diagnostics (Reusable IVD Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: In Vitro Diagnostics (Infectious Disease) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: In Vitro Diagnostics (Infectious Disease) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: In Vitro Diagnostics (Diabetes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: In Vitro Diagnostics (Diabetes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: In Vitro Diagnostics (Cancer/Oncology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: In Vitro Diagnostics (Cancer/Oncology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: In Vitro Diagnostics (Cardiology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: In Vitro Diagnostics (Cardiology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Global: In Vitro Diagnostics (Autoimmune Disease) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Global: In Vitro Diagnostics (Autoimmune Disease) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Global: In Vitro Diagnostics (Nephrology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Global: In Vitro Diagnostics (Nephrology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Global: In Vitro Diagnostics (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Global: In Vitro Diagnostics (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Global: In Vitro Diagnostics (Hospitals Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Global: In Vitro Diagnostics (Hospitals Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Global: In Vitro Diagnostics (Clinical Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Global: In Vitro Diagnostics (Clinical Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Global: In Vitro Diagnostics (Point-of-care Testing Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Global: In Vitro Diagnostics (Point-of-care Testing Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Global: In Vitro Diagnostics (Academic Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Global: In Vitro Diagnostics (Academic Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Global: In Vitro Diagnostics (Patients) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Global: In Vitro Diagnostics (Patients) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Global: In Vitro Diagnostics (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Global: In Vitro Diagnostics (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: North America: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: North America: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: United States: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: United States: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Canada: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Canada: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Asia-Pacific: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Asia-Pacific: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: China: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: China: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Japan: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Japan: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: India: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: India: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: South Korea: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: South Korea: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Australia: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Australia: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Indonesia: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Indonesia: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Others: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Others: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Europe: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Europe: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Germany: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Germany: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: France: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: France: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: United Kingdom: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: United Kingdom: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Italy: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 85: Italy: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 86: Spain: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 87: Spain: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 88: Russia: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 89: Russia: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 90: Others: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 91: Others: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 92: Latin America: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 93: Latin America: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 94: Brazil: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 95: Brazil: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 96: Mexico: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 97: Mexico: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 98: Others: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 99: Others: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 100: Middle East and Africa: In Vitro Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 101: Middle East and Africa: In Vitro Diagnostics Market: Breakup by Country (in %), 2024
  • Figure 102: Middle East and Africa: In Vitro Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 103: Global: In Vitro Diagnostics Industry: SWOT Analysis
  • Figure 104: Global: In Vitro Diagnostics Industry: Value Chain Analysis
  • Figure 105: Global: In Vitro Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: In Vitro Diagnostics Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: In Vitro Diagnostics Market Forecast: Breakup by Test Type (in Million USD), 2025-2033
  • Table 3: Global: In Vitro Diagnostics Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 4: Global: In Vitro Diagnostics Market Forecast: Breakup by Usability (in Million USD), 2025-2033
  • Table 5: Global: In Vitro Diagnostics Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 6: Global: In Vitro Diagnostics Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 7: Global: In Vitro Diagnostics Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 8: Global: In Vitro Diagnostics Market: Competitive Structure
  • Table 9: Global: In Vitro Diagnostics Market: Key Players